459 related articles for article (PubMed ID: 34398171)
1. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
[TBL] [Abstract][Full Text] [Related]
2. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
Suarez EA; Bateman BT; Hernandez-Diaz S; Straub L; McDougle CJ; Wisner KL; Gray KJ; Pennell PB; Lester B; Zhu Y; Mogun H; Huybrechts KF
JAMA Psychiatry; 2024 May; 81(5):477-488. PubMed ID: 38265792
[TBL] [Abstract][Full Text] [Related]
3. Association of Gestational Age at Birth With Symptoms of Attention-Deficit/Hyperactivity Disorder in Children.
Ask H; Gustavson K; Ystrom E; Havdahl KA; Tesli M; Askeland RB; Reichborn-Kjennerud T
JAMA Pediatr; 2018 Aug; 172(8):749-756. PubMed ID: 29946656
[TBL] [Abstract][Full Text] [Related]
4. Association between prenatal antipsychotic exposure and the risk of attention-deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta-analysis.
Wang Z; Yuen AS; Wong KH; Chan AY; Coghill D; Simonoff E; Lau WC; Wong IC; Park S; Man KK
Neurosci Biobehav Rev; 2024 May; 160():105635. PubMed ID: 38499117
[TBL] [Abstract][Full Text] [Related]
5. Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures.
Leppert B; Havdahl A; Riglin L; Jones HJ; Zheng J; Davey Smith G; Tilling K; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
JAMA Psychiatry; 2019 Aug; 76(8):834-842. PubMed ID: 31042271
[TBL] [Abstract][Full Text] [Related]
6. Association between maternal benzodiazepine or Z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan.
Meng LC; Lin CW; Lin YC; Huang ST; Chen YY; Shang CY; Wu CY; Chen LK; Chan KA; Hsiao FY
Lancet Psychiatry; 2023 Jul; 10(7):499-508. PubMed ID: 37353262
[TBL] [Abstract][Full Text] [Related]
7. Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium.
Kurth L; O'Shea TM; Burd I; Dunlop AL; Croen L; Wilkening G; Hsu TJ; Ehrhardt S; Palanisamy A; McGrath M; Churchill ML; Weinberger D; Grados M; Dabelea D
J Neurodev Disord; 2024 May; 16(1):26. PubMed ID: 38796448
[TBL] [Abstract][Full Text] [Related]
8. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts.
Alemany S; Avella-García C; Liew Z; García-Esteban R; Inoue K; Cadman T; López-Vicente M; González L; Riaño Galán I; Andiarena A; Casas M; Margetaki K; Strandberg-Larsen K; Lawlor DA; El Marroun H; Tiemeier H; Iñiguez C; Tardón A; Santa-Marina L; Júlvez J; Porta D; Chatzi L; Sunyer J
Eur J Epidemiol; 2021 Oct; 36(10):993-1004. PubMed ID: 34046850
[TBL] [Abstract][Full Text] [Related]
9. Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability.
Ahlqvist VH; Sjöqvist H; Dalman C; Karlsson H; Stephansson O; Johansson S; Magnusson C; Gardner RM; Lee BK
JAMA; 2024 Apr; 331(14):1205-1214. PubMed ID: 38592388
[TBL] [Abstract][Full Text] [Related]
10. Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring.
Harris GM; Wood M; Ystrom E; Nordeng H
JAMA Netw Open; 2022 Jun; 5(6):e2215333. PubMed ID: 35657626
[TBL] [Abstract][Full Text] [Related]
11. Association of Prenatal Acetaminophen Exposure Measured in Meconium With Risk of Attention-Deficit/Hyperactivity Disorder Mediated by Frontoparietal Network Brain Connectivity.
Baker BH; Lugo-Candelas C; Wu H; Laue HE; Boivin A; Gillet V; Aw N; Rahman T; Lepage JF; Whittingstall K; Bellenger JP; Posner J; Takser L; Baccarelli AA
JAMA Pediatr; 2020 Nov; 174(11):1073-1081. PubMed ID: 32986124
[TBL] [Abstract][Full Text] [Related]
12. Maternal intrahepatic cholestasis of pregnancy and neurodevelopmental conditions in offspring: A population-based cohort study of 2 million Swedish children.
Chen S; Ahlqvist VH; Sjöqvist H; Stephansson O; Magnusson C; Dalman C; Karlsson H; Lee BK; Gardner RM
PLoS Med; 2024 Jan; 21(1):e1004331. PubMed ID: 38227577
[TBL] [Abstract][Full Text] [Related]
13. Maternal Autistic Traits and Adverse Birth Outcomes.
Hosozawa M; Cable N; Ikehara S; Aochi Y; Tanigawa K; Baba S; Hirokawa K; Kimura T; Sobue T; Iso H;
JAMA Netw Open; 2024 Jan; 7(1):e2352809. PubMed ID: 38261317
[TBL] [Abstract][Full Text] [Related]
14. Maternal tobacco smoking and offspring autism spectrum disorder or traits in ECHO cohorts.
Hertz-Picciotto I; Korrick SA; Ladd-Acosta C; Karagas MR; Lyall K; Schmidt RJ; Dunlop AL; Croen LA; Dabelea D; Daniels JL; Duarte CS; Fallin MD; Karr CJ; Lester B; Leve LD; Li Y; McGrath M; Ning X; Oken E; Sagiv SK; Sathyanaraya S; Tylavsky F; Volk HE; Wakschlag LS; Zhang M; O'Shea TM; Musci RJ;
Autism Res; 2022 Mar; 15(3):551-569. PubMed ID: 35199959
[TBL] [Abstract][Full Text] [Related]
15. Levothyroxine Treatment Among Pregnant Women and Risk of Seizure in Children: A Population-Based Cohort Study.
Ge GM; Man KKC; Cheung ECL; Ip P; Leung WC; Kung AWC; Cheung CL; Wong ICK
Drug Saf; 2023 Nov; 46(11):1149-1159. PubMed ID: 37843760
[TBL] [Abstract][Full Text] [Related]
16. Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs.
Chan AYL; Gao L; Hsieh MH; Kjerpeseth LJ; Avelar R; Banaschewski T; Chan AHY; Coghill D; Cohen JM; Gissler M; Harrison J; Ip P; Karlstad Ø; Lau WCY; Leinonen MK; Leung WC; Liao TC; Reutfors J; Shao SC; Simonoff E; Tan KCB; Taxis K; Tomlin A; Cesta CE; Lai EC; Zoega H; Man KKC; Wong ICK
Nat Med; 2024 May; 30(5):1416-1423. PubMed ID: 38589601
[TBL] [Abstract][Full Text] [Related]
17. Parental ADHD and ASD symptoms and contributions of psychosocial risk to childhood ADHD and ASD symptoms in children born very preterm.
Liljenwall H; Lean RE; Smyser TA; Smyser CD; Rogers CE
J Perinatol; 2023 Apr; 43(4):458-464. PubMed ID: 35840709
[TBL] [Abstract][Full Text] [Related]
18. Extremely low gestational age and very low birthweight for gestational age are risk factors for autism spectrum disorder in a large cohort study of 10-year-old children born at 23-27 weeks' gestation.
Joseph RM; Korzeniewski SJ; Allred EN; O'Shea TM; Heeren T; Frazier JA; Ware J; Hirtz D; Leviton A; Kuban K;
Am J Obstet Gynecol; 2017 Mar; 216(3):304.e1-304.e16. PubMed ID: 27847193
[TBL] [Abstract][Full Text] [Related]
19. The causal association between maternal depression, anxiety, and infection in pregnancy and neurodevelopmental disorders among 410 461 children: a population study using quasi-negative control cohorts and sibling analysis.
Hope H; Pierce M; Gabr H; Radojčić MR; Swift E; Taxiarchi VP; Abel KM
Psychol Med; 2024 Jun; 54(8):1693-1701. PubMed ID: 38205522
[TBL] [Abstract][Full Text] [Related]
20. Preterm birth subtypes, placental pathology findings, and risk of neurodevelopmental disabilities during childhood.
Raghavan R; Helfrich BB; Cerda SR; Ji Y; Burd I; Wang G; Hong X; Fu L; Pearson C; Daniele Fallin M; Zuckerman B; Wang X
Placenta; 2019 Aug; 83():17-25. PubMed ID: 31477202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
